Business Of Biotech

241 Folgen

1. Pyxis Oncology's Lara Sullivan, M.D. On Site-Specific ADCs And Change Management

   Vom: 13.6.2022
2. The Biotech Beatdown With Allan Shaw

   Vom: 6.6.2022
3. Inflammation & Antibodies with Ampio Pharmaceuticals' Mike Martino, CEO

   Vom: 30.5.2022
4. What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D.

   Vom: 23.5.2022
5. Running Interference: RNAi with Silence Therapeutics' Craig Tooman

   Vom: 16.5.2022
6. Live Biologics & The Microbiome With 4D pharma's Duncan Peyton

   Vom: 9.5.2022
7. Gene Tx For Renal Disease With Purespring CEO Richard Francis

   Vom: 2.5.2022
8. Fighting Blindness & Funding The Fight With Opus Genetics' CEO Ben Yerxa, Ph.D.

   Vom: 25.4.2022
9. Gynecological Cancer Therapies with Context Therapeutics' Martin Lehr

   Vom: 18.4.2022
10. Commensal Viral Vectors with Ring Therapeutics' Tuyen Ong, M.D.

    Vom: 11.4.2022
11. Antibodies For Severe Allergies With IgGenix's Jessica Grossman, M.D.

    Vom: 4.4.2022
12. Gene Therapies For Ocular Disease With Sparing Vision's Stéphane Boissel

    Vom: 28.3.2022
13. Biotech M&A Trends With Allan Shaw

    Vom: 21.3.2022
14. Lipid Nanoparticle Gene Coding With SalioGen Therapeutics' Ray Tabibiazar, M.D.

    Vom: 14.3.2022
15. CAR T-cells For Ovarian Cancer with Anixa Biosciences' Amit Kumar, Ph.D.

    Vom: 7.3.2022
16. AI-Driven Biologics With Fountain Therapeutics' William Greene, M.D

    Vom: 28.2.2022
17. Regulatory Harmonization With Aurion Biotech's Dr. Daniela Drago

    Vom: 21.2.2022
18. Plant-Based Biologics With iBio's Randy Maddux

    Vom: 14.2.2022
19. NK Cell Therapy Accessibility With Shoreline Biosciences' Dr. Kleanthis Xanthopoulos

    Vom: 7.2.2022
20. A Hybrid mAb Manufacturing Model With John Glasspool

    Vom: 31.1.2022